These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8553340)

  • 1. [Status of ongoing controlled clinical trials on hypertension].
    Kjeldsen SE; Syvertsen JO; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1996 Jan; 116(1):61-3. PubMed ID: 8553340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Can treatment of hypertension prevent myocardial infarction? New controlled clinical trials are proposed].
    Kjeldsen SE; Syvertsen JO; Lund-Johansen P
    Tidsskr Nor Laegeforen; 1993 Feb; 113(6):737-40. PubMed ID: 8096658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current recommendations for the treatment of hypertension: are they still valid?
    Moser M
    J Hypertens Suppl; 2002 Feb; 20(1):S3-10. PubMed ID: 11996197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
    Hildebrandt PR; Tuxen CD; Kjeldsen SE; Lund-Johansen P; Hansson L
    Ugeskr Laeger; 2001 Dec; 164(1):18-21. PubMed ID: 11810791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An overview of hypertension studies with calcium antagonists].
    Kjeldsen SE; Midtbø K; Os I; Westheim A
    Tidsskr Nor Laegeforen; 1999 May; 119(13):1878-82. PubMed ID: 10382332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are the newer antihypertensive agents better and more effective than diuretics?].
    Landmark K
    Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treating hypertension is more important than the choice of agent; results from the largest clinical trial until now].
    de Leeuw PW; Birkenhäger WH
    Ned Tijdschr Geneeskd; 2003 Apr; 147(15):685-9. PubMed ID: 12722529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hypertension: angiotensin-II antagonists potentially better than beta-blockers in the occurrence of cardiovascular and cerebrovascular damage; the LIFE study in perspective].
    de Boer RA; van Veldhuisen DJ; Gans RO; Gansevoort RT
    Ned Tijdschr Geneeskd; 2003 Jan; 147(3):96-9. PubMed ID: 12577767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonist and beta blocker regimens found equally effective in hypertensive patients with coronary artery disease.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jan; 15(2):1, 5-6. PubMed ID: 14994735
    [No Abstract]   [Full Text] [Related]  

  • 14. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Tepel M
    Minerva Med; 2005 Aug; 96(4):277-85. PubMed ID: 16179894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial therapy for uncomplicated hypertension: insights from the alphabetic maze of recent studies.
    Stewart JR; Yeun JY
    Minerva Med; 2003 Aug; 94(4):215-27. PubMed ID: 14605587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of preventive effect of "new" and "old" antihypertensive agents].
    Kjeldsen SE; Syvertsen JO; Lund-Johansen P; Hildebrandt P; Hansson L
    Tidsskr Nor Laegeforen; 2001 Apr; 121(11):1374-6. PubMed ID: 11419108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensives after 70. The STOP-2 trial confirms key place for diuretics.
    Prescrire Int; 2001 Feb; 10(51):22. PubMed ID: 11503854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and emerging drug treatments for hypertension.
    Krum H; Pellizzer AM
    Aust Fam Physician; 1998 Apr; 27(4):235-7, 240-2. PubMed ID: 9581329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.